Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 637205, 7 pages
http://dx.doi.org/10.1155/2013/637205
Research Article

Synthesis and Antidepressant Activity of Some New 5-(1H-Indol-3-yl)-3-(substituted aryl)-4,5-dihydroisoxazoline Derivatives

Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, Dhule 425405, India

Received 20 June 2012; Revised 28 July 2012; Accepted 13 August 2012

Academic Editor: Volker Boehm

Copyright © 2013 Pravin O. Patil and Sanjay B. Bari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. E. Schechter, R. H. Ring, C. E. Beyer et al., “Innovative approaches for the development of antidepressant drugs: current and future strategies,” Neuro Therapeutics, vol. 2, no. 4, pp. 590–611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. V. Tran, F. P. Bymaster, R. K. McNamara, and W. Z. Potter, “Dual monoamine modulation for improved treatment of major depressive disorder,” Journal of Clinical Psychopharmacology, vol. 23, no. 1, pp. 78–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Biradar, B. S. Sasidhar, and R. Parveen, “Synthesis, antioxidant and DNA cleavage activities of novel indole derivatives,” European Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 4074–4078, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. A. RadwanRagab, N. M. Sabry, and S. M. Shenawy, “Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents,” Bioorganic and Medicinal Chemistry, vol. 15, no. 11, pp. 3832–3841, 2007. View at Publisher · View at Google Scholar
  5. S. S. Panda and P. V. R. Chaudhari, “Synthesis of novel indolyl-pyrimidine antiinflammatory, antioxidant and antibacterial agents,” Indian Journal of Pharmaceutical Sciences, vol. 70, no. 2, pp. 208–215, 2008. View at Publisher · View at Google Scholar
  6. M. Amir, S. A. Javed, and H. Kumar, “Design and synthesis of 3-[3-(substituted phenyl)-4-piperidin-1-ylmethyl/-4-morpholin-4-ylmethyl-4,5-dihydro-isoxazol-5-yl]-1H-indoles as potent anti-inflammatory agents,” Medicinal Chemistry Research, vol. 19, no. 3, pp. 299–310, 2010. View at Publisher · View at Google Scholar
  7. R. Patil and J. S. Biradar, “Synthesis and antimicrobial activity of 3-substituted phenyl-5-(5′-substituted-2′-phenylindol-3′-yl)-1,2-diazoles and 3-substituted phenyl-5-(5′-substituted-2′-phenylindol-3′-yl)-isoxazoles,” Asian Journal of Chemistry, vol. 11, no. 4, pp. 1127–1136, 1999. View at Google Scholar · View at Scopus
  8. M. Imran and S. A. Khan, “Synthesis, spectral characterization and antimicrobial activity of new isoxazoline derivatives,” Oriental Journal of Chemistry, vol. 19, pp. 695–697, 2003. View at Google Scholar
  9. A. Kamal, J. Surendranadha Reddy, M. Janaki Ramaiah et al., “Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents,” European Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 3924–3937, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Balachandran, P. K. Gadekar, S. Parkale et al., “Synthesis and biological activity of novel MIF antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 5, pp. 1508–1511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Padmaja, T. Payani, G. D. Reddy, and V. Padmavathi, “Synthesis, antimicrobial and antioxidant activities of substituted pyrazoles, isoxazoles, pyrimidine and thioxopyrimidine derivatives,” European Journal of Medicinal Chemistry, vol. 44, no. 11, pp. 4557–4566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Ahmad, P. K. Mishra, P. Gupta et al., “Synthesis of novel benzofuran isoxazolines as protein tyrosine phosphatase 1B inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 8, pp. 2139–2143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Traynor, “New drug and biological product approvals, 2011,” American Journal of Health-System Pharmacy, vol. 69, pp. 180–182, 2012. View at Publisher · View at Google Scholar
  14. N. Ergenec, N. S. Gunay, and S. Damirdamar, “Synthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives,” European Journal of Medicinal Chemistry, vol. 33, no. 2, pp. 143–148, 1998. View at Publisher · View at Google Scholar
  15. S. M. Shelke and S. H. Bhosale, “Synthesis, antidepressant evaluation and QSAR studies of novel 2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)-N-(substituted phenyl)acetamides,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 15, pp. 4661–4664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Varvaresou, T. Siatra-Papastaikoudi, A. Tsotinis, A. Tsantili-Kakoulidou, and A. Vamvakides, “Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4-thiadiazole and 1,2,4-triazole,” Farmaco, vol. 53, no. 5, pp. 320–326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. R. Prasad, P. R. Kumar, and B. Ramesh, International Journal of Chemical Sciences, vol. 5, no. 2, pp. 542–548, 2007.
  18. H. S. Youn, E. J. Lee, J. E. Lee et al., “Synthesis and biological evaluation of isoxazoline and isoxazole derivatives as 5-HT2A and 5-HT2C receptor ligands,” Bulletin of the Korean Chemical Society, vol. 30, no. 8, pp. 1873–1876, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Tiwari, A. Parvez, and J. Meshram, “Benign methodology and improved synthesis of 5-(2-chloroquinolin-3-yl)-3- phenyl-4,5-dihydroisoxazoline using acetic acid aqueous solution under ultrasound irradiation,” Ultrasonics Sonochemistry, vol. 18, no. 5, pp. 911–916, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. S. Panda, P. V. R. Chowdary, and B. S. Jayashree, “Synthesis, antiinflammatory and antibacterial activity of novel indolyl-isoxazoles,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 6, pp. 684–687, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kidwai, S. Kukreja, and R. Thakur, “K2CO3-mediated regioselective synthesis of isoxazoles and pyrazolines,” Letters in Organic Chemistry, vol. 3, no. 2, pp. 135–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Lidström, J. Tierney, B. Wathey, and J. Westman, “Microwave assisted organic synthesis—a review,” Tetrahedron, vol. 57, no. 45, pp. 9225–9283, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Caddick, “Microwave assisted organic reactions,” Tetrahedron, vol. 51, no. 38, pp. 10403–10432, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Philip James and H. R. Snyder, “INDOLE-3-ALDEHYDE,” Organic Syntheses, vol. 4, p. 539, 1963. View at Google Scholar
  25. M. Zahran and A. M. Ibrahm, “Synthesis and cellular cytotoxicities of new N-substituted indole-3-carbaldehyde and their indolylchalcones,” Journal of Chemical Sciences, vol. 121, no. 4, pp. 455–462, 2009. View at Publisher · View at Google Scholar
  26. X. H. Guo, X. X. Qi, and J. B. Chang, “5-(1H-indol-3-yl)-3-(4-methylphenyl)-4,5-dihydroisoxazoline,” Acta Crystallographica Section E, vol. 62, no. 1, pp. o374–o375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. D. Porsolt, M. Le Pichon, and M. Jalfre, “Depression: a new animal model sensitive to antidepressant treatments,” Nature, vol. 266, no. 5604, pp. 730–732, 1977. View at Google Scholar · View at Scopus
  28. OECD, 2001-gudeline on acute oral toxicity (AOT) Environmental health and safety monograph series on testing and adjustment No. 425.
  29. S. K. Kulkarni, Hand Book of Experimental Pharmacology, Vallabh Publications, Delhi, India, 3rd edition, 2007.
  30. R. P. Mahesh, B. K. Sharma, S. B. Gautam, and D. K. Pandey, International Journal of Pharma and Bio Sciences, vol. 1, pp. 1–6, 2010.